Ferring is a research-driven, specialty biopharmaceutical group committed to helping people build healthy families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.

There are three key areas that Ferring Pharmaceuticals is focused on: peptide-based medicine and in recombinant protein and biological therapeutics, as well as the company’s dedication to improving methods of medicine delivery, making it as patient-friendly as possible. Ferring Pharmaceuticals also focuses on developing new medicines.

Headquartered in Switzerland, Ferring employs 6,500 people worldwide. Ferring has operating subsidiaries in nearly 60 countries and we market our products in 140 countries. The main pharmaceutical development hub is in Copenhagen where 600 people primarily scientists and specialists are working to break new land to the benefit of patients globally.